35 TLR3 expressed by melanoma cells contributes to double-stranded RNA anti-tumoral effects in vivo

Bruno, Salaun; Asselin-Paturel, Carine; Morel, Yannis; Dubois, Clarisse; Charasson, Karine; Massacrier, Catherine; Rimoldi, Donata; Romero, Pedro

doi:10.1016/S0007-4551(15)31128-0

35 TLR3 expressed by melanoma cells contributes to double-stranded RNA anti-tumoral effects in vivo

Auteurs : Bruno S¹, Asselin-Paturel C¹, Morel Y¹, Dubois C¹, Charasson K¹, Massacrier C¹, Rimoldi D¹, Romero P¹

Affiliations : ¹Division of Clinical OncoImmunology, Ludwig Institute for Cancer Research, Lausanne, Switzerland

Date 2010 Mars, Vol 97, Num 1, Supplement, pp S31-S31Revue : Bulletin du cancerDOI : 10.1016/S0007-4551(15)31128-0

Aucun résumé disponible

Source : Elsevier-Masson

Accès à l'article

Accès restreint

Accès à distance aux ressources électroniques :

Exporter

Citer cet article

Bruno S, Asselin-Paturel C, Morel Y, Dubois C, Charasson K, Massacrier C, Rimoldi D, Romero P. 35 TLR3 expressed by melanoma cells contributes to double-stranded RNA anti-tumoral effects in vivo. Bull Cancer. 2010 Mar;97(1):S31-S31.

Indicateur SJR (2010) : 0.259